X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Bal Pharma Ltd.
BSE CODE: 524824   |   NSE CODE: BALPHARMA   |   ISIN CODE : INE083D01012   |   04-Apr-2025 Hrs IST
BSE NSE
Rs. 121.70
12.66 ( 11.61% )
 
Prev Close ( Rs.)
109.04
Open ( Rs.)
114.24
 
High ( Rs.)
128.86
Low ( Rs.)
113.26
 
Volume
118972
Week Avg.Volume
56153
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 122.23
13.89 ( 12.82% )
 
Prev Close ( Rs.)
108.34
Open ( Rs.)
114.95
 
High ( Rs.)
128.74
Low ( Rs.)
113.02
 
Volume
2593991
Week Avg.Volume
529406
 
52 WK High-Low Range(Rs.)
78.06
157.98
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)6.50  3.90  5.79  6.14  -6.28  
   CEPS(Rs)11.85  8.67  10.67  11.03  -1.32  
   DPS(Rs)1.20  1.00  1.00  1.00  0.00  
   Book NAV/Share(Rs)66.38  60.32  57.66  52.88  46.53  
   Tax Rate(%)15.14  28.34  28.84  7.14  1.92  
Margin Ratios          
   Core EBITDA Margin(%)9.64  8.72  8.36  10.63  4.11  
   EBIT Margin(%)8.13  6.97  8.08  8.80  2.12  
   Pre Tax Margin(%)3.58  2.82  4.30  3.93  -5.32  
   PAT Margin (%)3.03  2.02  3.06  3.65  -5.22  
   Cash Profit Margin (%)5.53  4.49  5.64  6.56  -1.10  
Performance Ratios          
   ROA(%)2.90  1.92  3.11  3.63  -3.59  
   ROE(%)10.30  6.80  10.47  12.61  -12.47  
   ROCE(%)11.95  10.40  12.28  12.57  2.09  
   Asset Turnover(x)0.95  0.95  1.02  1.00  0.69  
   Sales/Fixed Asset(x)3.02  3.04  3.15  2.96  2.15  
   Working Capital/Sales(x)4.70  5.24  5.38  5.38  5.93  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.33  0.33  0.32  0.34  0.46  
   Receivable days106.71  104.01  95.91  88.65  125.48  
   Inventory Days99.83  103.36  87.29  93.46  146.56  
   Payable days187.52  190.52  144.48  114.32  209.22  
Valuation Parameters          
   PER(x)14.04  17.14  18.63  8.76  0.00  
   PCE(x)7.70  7.72  10.11  4.87  -24.60  
   Price/Book(x)1.37  1.11  1.87  1.02  0.70  
   Yield(%)1.32  1.49  0.93  1.86  0.00  
   EV/Net Sales(x)0.78  0.74  0.90  0.72  0.84  
   EV/Core EBITDA(x)7.36  7.79  8.46  6.17  13.40  
   EV/EBIT(x)9.62  10.54  11.16  8.21  39.42  
   EV/CE(x)1.11  1.01  0.87  0.98  0.60  
   M Cap / Sales0.43  0.35  0.57  0.32  0.27  
Growth Ratio          
   Net Sales Growth(%)11.69  8.11  12.46  46.07  -23.49  
   Core EBITDA Growth(%)25.70  -4.26  2.39  174.27  -54.18  
   EBIT Growth(%)30.21  -6.69  3.27  506.36  -78.86  
   PAT Growth(%)67.68  -28.59  -5.69  202.19  -231.69  
   EPS Growth(%)66.46  -32.54  -5.69  197.71  -231.69  
Financial Stability Ratios          
   Total Debt/Equity(x)1.28  1.32  1.15  1.33  1.51  
   Current Ratio(x)1.34  1.27  1.31  1.32  1.21  
   Quick Ratio(x)0.93  0.81  0.87  0.91  0.73  
   Interest Cover(x)1.79  1.68  2.14  1.81  0.29  
   Total Debt/Mcap(x)0.93  1.19  0.61  1.31  2.16